Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PSCK9)

• 收藏
• 分享

专利权人:

Inc.;Regeneron Pharmaceuticals

发明人:

Swergold, Gary

申请号：

AU2012308797

公开号：

AU2012308797B2

申请日:

2012.09.12

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

The present invention provides methods for reducing lipoprotein(a) (Lp(a)) in patients. The methods of the present invention comprise selecting a patient who exhibits elevated serum Lp(a), and administering to the patient a pharmaceutical composition comprising a PCSK9 inhibitor. In certain embodiments, the PCSK9 inhibitor is an anti-PCSK9 antibody such as the exemplary antibody referred to herein as mAb316P.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/